These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 39069012

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer.
    Ukkola I, Nummela P, Pasanen A, Kero M, Lepistö A, Kytölä S, Bützow R, Ristimäki A.
    Virchows Arch; 2021 Sep; 479(3):471-479. PubMed ID: 33755781
    [Abstract] [Full Text] [Related]

  • 4. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases].
    Liu Y, Guo YH, Luo Y, Sun L, Zhao S, Shao B, Zang FL, Qiu ZQ, Sun BC, Sun Y.
    Zhonghua Bing Li Xue Za Zhi; 2021 Apr 08; 50(4):369-375. PubMed ID: 33831997
    [Abstract] [Full Text] [Related]

  • 5. Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers.
    Riedinger CJ, Esnakula A, Haight PJ, Suarez AA, Chen W, Gillespie J, Villacres A, Chassen A, Cohn DE, Goodfellow PJ, Cosgrove CM.
    Cancer; 2024 Feb 01; 130(3):385-399. PubMed ID: 37751191
    [Abstract] [Full Text] [Related]

  • 6. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
    Liu Y, Wang YX, Sun XJ, Ting X, Wu R, Liu XD, Liu CR.
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct 25; 58(10):755-765. PubMed ID: 37849256
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing.
    Smithgall MC, Remotti H, Hsiao SJ, Mansukhani M, Liu-Jarin X, Fernandes H.
    Hum Pathol; 2022 Jan 25; 119():41-50. PubMed ID: 34666078
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical Targeted Next-Generation Sequencing Shows Increased Mutational Load in Endometrioid-type Endometrial Adenocarcinoma With Deficient DNA Mismatch Repair.
    Lee PJ, McNulty S, Duncavage EJ, Heusel JW, Hagemann IS.
    Int J Gynecol Pathol; 2018 Nov 25; 37(6):581-589. PubMed ID: 29084048
    [Abstract] [Full Text] [Related]

  • 11. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.
    McConechy MK, Talhouk A, Li-Chang HH, Leung S, Huntsman DG, Gilks CB, McAlpine JN.
    Gynecol Oncol; 2015 May 25; 137(2):306-10. PubMed ID: 25636458
    [Abstract] [Full Text] [Related]

  • 12. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
    Jin W, Wang LQ, Liu Y, Liu AJ.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec 25; 53(12):823-830. PubMed ID: 30585020
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, Chen LM.
    Am J Surg Pathol; 2014 Jun 25; 38(6):793-800. PubMed ID: 24503759
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
    Timmerman S, Van Rompuy AS, Van Gorp T, Vanden Bempt I, Brems H, Van Nieuwenhuysen E, Han SN, Neven P, Victoor J, Laenen A, Vergote I.
    Gynecol Oncol; 2020 Apr 25; 157(1):245-251. PubMed ID: 31980219
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Tissue Mismatch Repair Protein Deficiency between Early- and Advanced-Stage Endometrial Cancer.
    Chaowiwatkun K, Trongwongsa T, Rodpenpear N, Nutthachote P.
    Asian Pac J Cancer Prev; 2023 Jan 01; 24(1):345-351. PubMed ID: 36708586
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.
    Salem ME, Bodor JN, Puccini A, Xiu J, Goldberg RM, Grothey A, Korn WM, Shields AF, Worrilow WM, Kim ES, Lenz HJ, Marshall JL, Hall MJ.
    Int J Cancer; 2020 Nov 15; 147(10):2948-2956. PubMed ID: 32449172
    [Abstract] [Full Text] [Related]

  • 20. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations.
    Haraldsdottir S, Hampel H, Tomsic J, Frankel WL, Pearlman R, de la Chapelle A, Pritchard CC.
    Gastroenterology; 2014 Dec 15; 147(6):1308-1316.e1. PubMed ID: 25194673
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.